Some drugs can be prescribed regardless of mutation or receptor status at certain stages of a disease. Other drugs can be prescribed regardless of disease if a certain gene mutation is identified in the patient.

As such, the field of pharmaceuticals is evolving at a rapid pace. New drugs that are no longer attached to a specific disease are emerging, introduced as all-comers or disease-agnostic drugs. And the emergence of these drugs is heralding a paradigm shift.

However, the new drugs are not easily granted reimbursement in Korea. Due to the broad application of the drugs, the government has to consider how their increased use volume may raise financial concern.

For all